Circulating miR-106b-3p, miR-101-3p and miR-1246 as diagnostic biomarkers of hepatocellular carcinoma
Farzaneh Moshiri(University of Ferrara), Massimo Negrini(University of Ferrara), Ram C. Shankaraiah(University of Ferrara), Alessandro Salvi(University of Brescia), Arash Sattari(University of Verona), Angelo Sangiovanni(Ospedale Maggiore), Laura Lupini(University of Ferrara), Dario Veneziano(The Ohio State University), Paolo Carcoforo(University of Ferrara), Douglas G. Cheung(The Ohio State University), Giuseppina De Petro(University of Brescia), Giovanni Nigita(The Ohio State University), Luigi Bolondi(University of Bologna), Antonio Frassoldati(Italian Oncology Group of Clinical Research), Nazario Portolani(Azienda Socio Sanitaria Territoriale degli Spedali Civili di Brescia), Francesca Fornari(University of Bath), Carlo M. Croce(The Ohio State University), Laura Gramantieri(Second Military Medical University), Silvia Sabbioni(University of Ferrara), Cristian Bassi(University of Ferrara), Massimo Colombo(IRCCS Humanitas Research Hospital), Paola Guerriero(University of Ferrara)
Cited by 98
Related Papers
The role of MicroRNAs in human cancer
|Signal Transduction and Targeted Therapy|2016|2.5k
MicroRNA Expression Profiles Associated With Prognosis and Therapeutic Outcome in Colon Adenocarcinoma
|JAMA|2008|1.6k
MicroRNAs bind to Toll-like receptors to induce prometastatic inflammatory response
|Proceedings of the National Academy of Sciences|2012|1.5k
MicroRNA profiling reveals distinct signatures in B cell chronic lymphocytic leukemias
|Proceedings of the National Academy of Sciences|2004|1.3k
Efficacy and safety of sorafenib in patients with advanced hepatocellular carcinoma: Subanalyses of a phase III trial
|Journal of Hepatology|2012|821